Mapping Aggressive Fibromatosis: Targeting Fibroblast Activated Protein (FAP) Using Radiolabelled Inhibitors ( 68 Ga - FAPI) PET/CT
Indian Journal of Nuclear Medicine · 01.06.2026 · 41 · 345-350
DOI: 10.25259/ijnm_27_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Nuclear Medicine, online erschienen am 01.06.2026. Verfasst von Sneha Shah und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
The case collection illustrates the ability of the 68 Ga labelled FAPI in delineating extent of disease and mapping the disease especially unearthing multifocal disease which might alter management. These cases also portray the potential use of FAPI as a carrier for theranostics, offering a tumor specific conformal ablative treatment for the intrusive debilitating pathology especially when surgery is not feasible.
Zitieren
APA
Shah, S., Purandare, N. C., Rangarajan, V., Puranik, A., Agrawal, A., & Choudhury, S. (2026). Mapping Aggressive Fibromatosis: Targeting Fibroblast Activated Protein (FAP) Using Radiolabelled Inhibitors ( 68 Ga - FAPI) PET/CT. Indian Journal of Nuclear Medicine, 41, 345-350. https://doi.org/10.25259/ijnm_27_2026
Vancouver
Shah S, Purandare NC, Rangarajan V, Puranik A, Agrawal A, Choudhury S. Mapping Aggressive Fibromatosis: Targeting Fibroblast Activated Protein (FAP) Using Radiolabelled Inhibitors ( 68 Ga - FAPI) PET/CT. Indian Journal of Nuclear Medicine. 2026;41:345-350. doi:10.25259/ijnm_27_2026
BibTeX
@article{Shah2026,
author = {Shah, Sneha and Purandare, Nilendu C and Rangarajan, Venkatesh and Puranik, Ameya and Agrawal, Archi and Choudhury, Sayak},
title = {Mapping Aggressive Fibromatosis: Targeting Fibroblast Activated Protein (FAP) Using Radiolabelled Inhibitors ( 68 Ga - FAPI) PET/CT},
journal = {Indian Journal of Nuclear Medicine},
year = {2026},
volume = {41},
pages = {345--350},
doi = {10.25259/ijnm_27_2026}
}
EUVIMED